IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm,...

Nature Cancer - In the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial, Platten and colleagues report the long-term clinical and immunological follow-up outcomes of a...